Genexine completes private placement of convertible preferred stock

Genexine Inc. (KOSDAQ:095700), Seoul, South Korea Business: Endocrine/Metabolic, Cancer, Hematology Date completed: 2016-06-29 Type: Private placement of convertible preferred stock Raised: W60 billio...